
Liminal BioSciences LMNL
Quartalsbericht 2022-Q2
hinzugefügt 10.08.2022
Liminal BioSciences Langfristiger Schuldenstrom 2011-2026 | LMNL
Langfristiger Schuldenstrom Jährlich Liminal BioSciences
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| - | 6.95 M | 8.29 M | - | - | - | - | - | - | - | - |
Alle Zahlen in CAD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 8.29 M | 6.95 M | 7.62 M |
Langfristiger Schuldenstrom anderer Aktien in der Pharmaeinzelhändler
| Name | Langfristiger Schuldenstrom | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
675 K | $ 9.33 | 1.41 % | $ 603 M | ||
|
MorphoSys AG
MOR
|
3.63 M | - | 2.43 % | $ 254 M | ||
|
I-Mab
IMAB
|
8.06 M | - | - | $ 866 M | ||
|
Aptorum Group Limited
APM
|
433 K | $ 0.87 | -2.13 % | $ 6.4 M | ||
|
ACADIA Pharmaceuticals
ACAD
|
9.96 M | $ 22.38 | 0.81 % | $ 3.71 B | ||
|
Applied Molecular Transport
AMTI
|
4.64 M | - | - | $ 10.1 M | ||
|
Galapagos NV
GLPG
|
1.73 M | $ 28.15 | 1.04 % | $ 2.69 B | ||
|
Advaxis
ADXS
|
166 K | - | -9.65 % | $ 45.9 M | ||
|
Grifols, S.A.
GRFS
|
117 M | $ 8.22 | 3.92 % | $ 6.83 B | ||
|
Harmony Biosciences Holdings
HRMY
|
1.07 M | $ 30.95 | -0.34 % | $ 1.78 B | ||
|
ImmuCell Corporation
ICCC
|
85.5 K | $ 8.43 | -0.12 % | $ 76.1 M | ||
|
InflaRx N.V.
IFRX
|
257 K | $ 1.97 | -0.51 % | $ 152 M | ||
|
Incyte Corporation
INCY
|
5.7 M | $ 98.55 | -0.55 % | $ 19.2 B | ||
|
InMed Pharmaceuticals
INM
|
376 K | $ 0.71 | 1.27 % | $ 1.74 M | ||
|
Innoviva
INVA
|
418 K | $ 22.97 | -0.35 % | $ 1.55 B | ||
|
Aeterna Zentaris
AEZS
|
215 K | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
181 K | - | -10.17 % | $ 12.2 K | ||
|
Brainstorm Cell Therapeutics
BCLI
|
208 K | - | -2.5 % | $ 5.88 M | ||
|
BioNTech SE
BNTX
|
45 M | $ 104.02 | 2.41 % | $ 27.2 B | ||
|
Aeglea BioTherapeutics
AGLE
|
625 K | - | - | $ 1.01 B | ||
|
Jaguar Health
JAGX
|
192 K | $ 7.34 | -6.79 % | $ 17.1 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
1.27 M | - | - | $ 26.5 M | ||
|
AIkido Pharma
AIKI
|
554 K | - | 1.93 % | $ 17.4 M | ||
|
KalVista Pharmaceuticals
KALV
|
1.62 M | $ 26.68 | 0.02 % | $ 1.44 B | ||
|
Kamada Ltd.
KMDA
|
2.12 M | $ 8.16 | 0.68 % | $ 260 M | ||
|
Krystal Biotech
KRYS
|
1.77 M | $ 260.24 | 0.11 % | $ 7.53 B | ||
|
Akouos
AKUS
|
671 K | - | 0.23 % | $ 488 M | ||
|
Allakos
ALLK
|
3.25 M | - | - | $ 28.6 M | ||
|
Ligand Pharmaceuticals Incorporated
LGND
|
1.27 M | $ 220.06 | -2.13 % | $ 4.02 B | ||
|
AlloVir
ALVR
|
316 K | - | 4.14 % | $ 49.1 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
43 K | $ 2.94 | -1.67 % | $ 4.84 M | ||
|
Liquidia Corporation
LQDA
|
900 K | $ 38.41 | 0.67 % | $ 3.31 B | ||
|
Ampio Pharmaceuticals
AMPE
|
274 K | - | -11.43 % | $ 502 K | ||
|
CureVac N.V.
CVAC
|
3.47 M | - | - | $ 867 M | ||
|
Applied Therapeutics
APLT
|
429 K | - | - | $ 8.42 M | ||
|
Aptose Biosciences
APTO
|
193 K | - | -45.71 % | $ 1.2 M | ||
|
Aquestive Therapeutics
AQST
|
631 K | $ 4.08 | 0.62 % | $ 436 M | ||
|
Aptinyx
APTX
|
337 K | - | -39.0 % | $ 4.57 M | ||
|
Aravive
ARAV
|
2.2 M | - | -13.39 % | $ 1.45 M | ||
|
Aridis Pharmaceuticals
ARDS
|
538 K | - | 17.91 % | $ 11.1 M | ||
|
Arcutis Biotherapeutics
ARQT
|
294 K | $ 23.15 | 3.49 % | $ 2.95 B |